Health

Pharmaceutical Industry Disputes

Updated 2026-10-28 13:50 UTC 1 source Negative

Missouri's attorney general has warned Eli Lilly to discontinue requiring hospitals to provide claims data for discounted medicines under the 340B program. This marks a new battle in the ongoing pharmaceutical industry disputes.

Coverage timeline — 1 article

STAT News

STAT+: Pharmalittle: We’re reading about 340B battles, new results for a Lilly weight loss drug, and more

Missouri attorney general warned Eli Lilly to discontinue requiring hospitals to provide claims data to receive discounted medicines under 340B program

2026-10-28 13:44 UTC